Literature DB >> 19162480

Staphylococcus aureus as an intracellular pathogen: the role of small colony variants.

Parham Sendi1, Richard A Proctor.   

Abstract

Increasing evidence indicates that Staphylococcus aureus might be a facultative intracellular pathogen. In particular, certain subpopulations, called small colony variants (SCVs), seem to be well adapted to the intracellular milieu. When compared to 'normal' staphylococcal strains, SCVs show increased uptake by host cells, resistance to intracellular defenses and reduced stimulation of host defenses. We propose that the ability to form two subpopulations with different phenotypes might allow S. aureus the option for both extra- cellular and intra-cellular survival in the host.

Entities:  

Mesh:

Year:  2009        PMID: 19162480     DOI: 10.1016/j.tim.2008.11.004

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  100 in total

1.  Phagolysosomal integrity is generally maintained after Staphylococcus aureus invasion of nonprofessional phagocytes but is modulated by strain 6850.

Authors:  Thiên-Trí Lâm; Bernd Giese; Deepak Chikkaballi; Anika Kühn; Wanja Wolber; Jan Pané-Farré; Daniel Schäfer; Susanne Engelmann; Martin Fraunholz; Bhanu Sinha
Journal:  Infect Immun       Date:  2010-06-07       Impact factor: 3.441

2.  Role of mutations in dihydrofolate reductase DfrA (Rv2763c) and thymidylate synthase ThyA (Rv2764c) in Mycobacterium tuberculosis drug resistance.

Authors:  Claudio U Köser; Richard N Veerapen-Pierce; David K Summers; John A C Archer
Journal:  Antimicrob Agents Chemother       Date:  2010-10       Impact factor: 5.191

3.  PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates.

Authors:  S Wesley Long; Randall J Olsen; Shrenik C Mehta; Timothy Palzkill; Patricia L Cernoch; Katherine K Perez; William L Musick; Adriana E Rosato; James M Musser
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

4.  Gentamicin-Loaded Polysaccharide Membranes for Prevention and Treatment of Post-operative Wound Infections in the Skeletal System.

Authors:  Urszula Cibor; Małgorzata Krok-Borkowicz; Monika Brzychczy-Włoch; Łucja Rumian; Krzysztof Pietryga; Dominika Kulig; Wojciech Chrzanowski; Elżbieta Pamuła
Journal:  Pharm Res       Date:  2017-06-21       Impact factor: 4.200

Review 5.  Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus.

Authors:  Timothy J Foster; Joan A Geoghegan; Vannakambadi K Ganesh; Magnus Höök
Journal:  Nat Rev Microbiol       Date:  2014-01       Impact factor: 60.633

6.  Escherichia coli variants in periprosthetic joint infection: diagnostic challenges with sessile bacteria and sonication.

Authors:  Parham Sendi; Reno Frei; Thomas B Maurer; Andrej Trampuz; Werner Zimmerli; Peter Graber
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

Review 7.  Treatment algorithms for chronic osteomyelitis.

Authors:  Gerhard Walter; Matthias Kemmerer; Clemens Kappler; Reinhard Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2012-04-06       Impact factor: 5.594

8.  Staphylococcal alpha-toxin is not sufficient to mediate escape from phagolysosomes in upper-airway epithelial cells.

Authors:  Bernd Giese; Silvia Dittmann; Kerstin Paprotka; Katja Levin; Annett Weltrowski; Diana Biehler; Thiên-Trí Lâm; Bhanu Sinha; Martin J Fraunholz
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

9.  Identification of point mutations in clinical Staphylococcus aureus strains that produce small-colony variants auxotrophic for menadione.

Authors:  Melissa A Dean; Randall J Olsen; S Wesley Long; Adriana E Rosato; James M Musser
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

10.  Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells.

Authors:  Gabriel Mitchell; Mariza Gattuso; Gilles Grondin; Éric Marsault; Kamal Bouarab; François Malouin
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.